Angt Bio
昂拓生物
Angt Bio
Biotech/Healthcare
Angtuo Bio is a biopharmaceutical R&D company building an antisense oligonucleotide-based drug development platform. It develops nucleic acid therapeutics for common metabolic diseases and severe rare diseases, with targets both in and outside the liver.
Latest round: Seed (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.